Prevalence of symptoms of anxiety and depression one year after intensive care unit admission for COVID-19.

"Declarations Ethics approval and consent to participateEthical approval for the GOT-RECOV-19 ICU study was obtained on September 24, 2020 (ID number: 2020–03264) from the Swedish Ethical Review Authority. An addendum to the ethical approval, for sending reminder mails to the participants, was also approved, on June 29, 2021 (ID number: 2021–03220). All participants gave informed and written consent prior to their participation in the study. All methods were performed in accordance with the relevant regulations of the Swedish Ethical Review Authority and the Declaration of Helsinki [27]. All participants’ data were collected, stored and processed following the General Data Protection Regulation (GDPR). Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding Open access funding provided by University of Gothenburg. The study was performed in the researchers’ capacity as employees of Sahlgrenska University Hospital, University of Gothenburg, and University of Nottingham."

"Trial registration The study was registered at researchweb.org on 28 May 2020 (Project number: 274477)."